Chicago Partners Investment Group LLC boosted its position in Danaher Corporation (NYSE:DHR – Free Report) by 42.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,964 shares of the conglomerate’s stock after acquiring an additional 4,488 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in Danaher were worth $2,754,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. State Street Corp lifted its position in shares of Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after purchasing an additional 472,608 shares during the last quarter. Capital International Investors grew its stake in shares of Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after purchasing an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Danaher by 9.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after buying an additional 1,334,221 shares during the last quarter. Wellington Management Group LLP increased its holdings in Danaher by 11.2% in the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after buying an additional 1,517,904 shares during the last quarter. Finally, Norges Bank acquired a new stake in Danaher in the fourth quarter valued at $2,177,106,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Stock Performance
Shares of DHR stock opened at $200.45 on Tuesday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The firm has a market cap of $141.87 billion, a price-to-earnings ratio of 38.77, a PEG ratio of 2.54 and a beta of 0.79. The stock’s 50-day moving average is $181.02 and its two-hundred day moving average is $199.06.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio is currently 30.95%.
Analyst Ratings Changes
Several research analysts have recently issued reports on DHR shares. Guggenheim lowered their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. TD Cowen cut their target price on Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 target price on Danaher in a research note on Friday, April 17th. Piper Sandler initiated coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target for the company. Finally, DZ Bank assumed coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $231.64.
Check Out Our Latest Stock Analysis on DHR
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
